latest news releases from the newsroom
GenTek Inc. Reports Third Quarter 2008 Results; Posts An 18 Percent Increase in Revenue and a 42 Percent Improvement in Adjusted EBITDA
PARSIPPANY, N.J., Nov. 10, 2008 (GLOBE NEWSWIRE) -- GenTek Inc. (Nasdaq:GETI) today announced results for the third quarter ended September 30, 2008. For the third quarter of 2008, GenTek had revenues totaling $178.7 million and operating profit of $17.4 million, after a $0.9 million restructuring charge. This compares to revenues of $151.3 million and operating profit of $20.4 million in the prior-year period, after a gain on disposition of long-term assets of $10.1 million and income from pension curtailments net of restructuring and impairment charges of $0.9 million. Strong revenue and operating profit results in the performance chemicals segment were partly offset by weakness in the valve actuation systems segment and the industrial wire market. The Company recorded income from continuing operations of $7.3 million, or $0.67 per diluted share, compared to income from continuing operations of $8.6 million, or $0.75 per diluted share, in the third quarter of 2007.
Universal Stainless & Alloy Products
Universal Stainless Reduces 2008 Fourth Quarter EPS Guidance Due to Lower Raw Material Prices
BRIDGEVILLE, Pa., Nov. 10, 2008 (GLOBE NEWSWIRE) -- In its quarterly report on Form 10-Q filed today, Universal Stainless & Alloy Products, Inc. (Nasdaq:USAP) updated its business outlook for the fourth quarter of 2008 previously reported in its earnings release and 8-K filing of September 23, 2008. In updating its outlook, the Company confirmed its forecast of consolidated sales in the range of $45 to $55 million, including sales of $10 to $12 million from its Dunkirk Special Steel segment. However, it now expects that diluted EPS will range from breakeven to $0.15 due to lower raw material prices. The details of its revised outlook follow.
Medicis Pharmaceutical Corporation
Medicis Reports Third Quarter 2008 Financial Results
SCOTTSDALE, Ariz., Nov. 10, 2008 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced net revenues of approximately $115.4 million for the three months ended September 30, 2008, compared to net revenues of approximately $111.0 million for the three months ended September 30, 2007, restated, which represents an increase of approximately $4.4 million, or approximately 4.0%.
Dionex Enters Into Agreement With Caliper Life Sciences to Acquire Product Line for Water Sample Preparation
SUNNYVALE, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- Dionex, Inc. (Nasdaq:DNEX), a leading provider of liquid chromatography analysis instrumentation has entered into an agreement with Caliper Life Sciences, Inc., to purchase Caliper's AutoTrace(r) line of products, which had sales of $3.1 million in 2007. The AutoTrace SPE workstation automates the extraction of large volume aqueous samples prior to analysis. It is a globally established platform with approved methods and applications such as the EPA 500 and 600 series for environmental testing of drinking water.
Main Street Capital Corporation
Main Street Capital Announces Third Quarter 2008 Financial Results
HOUSTON, Nov. 10, 2008 (GLOBE NEWSWIRE) -- Main Street Capital Corporation (Nasdaq:MAIN) ("Main Street") announces its financial results for the third quarter ended September 30, 2008 and provides dividend guidance for calendar year 2009.
MediciNova Reports Third Quarter 2008 Results
SAN DIEGO, Nov. 10, 2008 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today announced financial results for the third quarter ended September 30, 2008.
SenoRx Reports Third Quarter 2008 Gross Margin Expands to 65.0 Percent From 60.1 Percent a Year Ago; Revenue Grew 26.5 Percent for the Quarter and 34.0 Percent for the First Nine Months of 2008
IRVINE, Calif., Nov. 10, 2008 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today reported financial results for its third quarter ended September 30, 2008. Revenue for the quarter increased 26.5 percent to $11.3 million compared with $8.9 million in the third quarter a year ago. Gross profit increased 36.8 percent to $7.3 million, or 65.0 percent of revenue, up from $5.4 million, or 60.1 percent of revenue, in the third quarter of 2007.
EvergreenBancorp Declares Stock Dividend of 5 Percent and Cash Dividend of $0.035 Per Share
SEATTLE, Nov. 10, 2008 (GLOBE NEWSWIRE) -- EvergreenBancorp, Inc. (OTCBB:EVGG), the holding company for EvergreenBank, today announced its Board of Directors has declared a 5% stock dividend. In addition, shareholders will receive a cash dividend of $0.035 per share. The stock and cash dividends will be paid December 3, 2008, to shareholders of record November 19, 2008.